| MiCBT Research – selected studies

Managing type 2 diabetes and depression with Mindfulness-integrated Cognitive Behavior Therapy (MiCBT)

Fateh Sohrabi1 · Ahmad Sohrabi2 · Narges Shams‑Alizadeh3 · Bruno A. Cayoun4

1Department of Psychology, Shahid Beheshti University of Tehran, Tehran, Iran.
2Department of Psychology, University of Kurdistan, Sanandaj, Iran.
3Kurdistan Research Center for Social Determinants of Health, Kurdistan University of Medical Sciences, Sanandaj, Iran.
4MiCBT Institute, Hobart TAS, Australia.


Diabetes Mellitus (DM) is the most common metabolic disorder and the most common cause of death in eastern populations, with prevalence estimated to be at the level of epidemic illness. Despite medical attention, psychological factors remain a significant contributor to DM, requiring effective psychological interventions. This study evaluated the effects of Mindfulness-integrated Cognitive Behavior Therapy (MiCBT) on depression, treatment adherence, and control of blood glucose of 25 Iranian patients (11 males and 14 females, mean age = 45.6) with type 2 DM, randomly assigned to either an 8-session MiCBT (n = 12) or treatment-as-usual (TAU) (n = 13). We present a theoretical conceptualization and detailed step-by-step implementation of MiCBT, and an assessment of its effectiveness in this sample. While no between-group differences were found at pre-treatment on any of the measures, the MiCBT group showed a significantly greater reduction in depression and greater treatment adherence than the TAU group at post-treatment. The MiCBT group also showed a significantly greater blood sugar reduction than the TAU group at 6-week follow-up. Within-group analysis found no significant change on any of the measures for TAU, whereas the MiCBT group reported a significant decrease in depression and increase in treatment adherence from pre- to post-treatment and maintained at 6-week follow-up. Blood sugar reduction also only occurred in the MiCBT group from pre- to post-treatment. Replication studies with larger samples are necessary to confirm these findings and validate the transdiagnostic efficacy and transcultural applicability of MiCBT in type 2 DM.

Read the full article here:
Springer journal (Discover Psychology. Volume: 2. Issue: 1. 2021).

Share on facebook
Share on twitter
Share on linkedin

Validation and Factor Structure of the Mindfulness‑Based Self Efficacy Scale‑Revised

February 7, 2022

Managing type 2 diabetes and depression with Mindfulness-integrated Cognitive Behavior Therapy (MiCBT)

February 2, 2022

The Effectiveness of Mindfulness-integrated Cognitive Behavioral Therapy (MiCBT), Meta-Cognitive Therapy (MCT), Acceptance and Commitment Therapy (ACT), and Cognitive Behavioral Therapy (CBT) on Obsessive-compulsive disorder (OCD)

October 15, 2021

Combined identification of lncRNA NONHSAG004550 and NONHSAT125420 as a potential diagnostic biomarker of perinatal depression

June 15, 2021

Co-emergence Reinforcement and Its Relevance to Interoceptive Desensitization in Mindfulness and Therapies Aiming at Transdiagnostic Efficacy

December 29, 2020

Development and Validation of the Equanimity Scale-16

October 3, 2020

Effectiveness of Mindfulness-integrated Cognitive Behavioral Therapy on the emotional states and quality of life of patients with multiple sclerosis: A clinical trial study

May 13, 2020

Effectiveness of mindfulness-integrated cognitive behavior therapy on anxiety, depression and hope in multiple sclerosis patients: a randomized clinical trial

April 17, 2020

Study protocol for a randomized control trial to investigate the effectiveness of an 8-week mindfulness-integrated cognitive behavior therapy (MiCBT) transdiagnostic group intervention for primary care patients

February 9, 2020

The Effectiveness of Mindfulness-Integrated Cognitive-Behavioral Therapy on Sleep Quality, Anxiety, and Fatigue in Patients with Multiple Sclerosis: A Randomized Clinical Trial

December 15, 2019
Scroll to Top
Forgot Password
Enter your email address or username and we’ll send you instructions to reset your password.